CD8A and cancer: Since one primary goal in the field of tumor immunology is to increase the immunogenicity of tumor cells by re-establishing and maintaining MHC class I surface expression, the identification of key molecules or substances overriding these tumor intrinsic escape routes will help to improve durable elimination of cancer cells by CD8+ T cells.